1. A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine. (August 2016) Authors: Voss, Tiffini; Lipton, Richard B; Dodick, David W; Dupre, Nicole; Ge, Joy Yang; Bachman, Robert; Assaid, Christopher; Aurora, Sheena K; Michelson, David Journal: Cephalalgia Issue: Volume 36:Number 9(2016) Page Start: 887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine. (February 2016) Authors: Ho, Tony W; Ho, Andrew P; Ge, Yang (Joy); Assaid, Christopher; Gottwald, Regina; MacGregor, E Anne; Mannix, Lisa K; van Oosterhout, Willebrordus PJ; Koppenhaver, Janelle; Lines, Christopher; Ferrari, Michel D; Michelson, David Journal: Cephalalgia Issue: Volume 36:Number 2(2016) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗